Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)

REFERENCES

• Alfthan, O. & Rusk, J. 1969. Estracyt in advanced prostatic carcinoma. Ann Chir Gynaecol Fenn 58, 234.
   PubMedGoogle Scholar
• Anderes, A., Arquint, A., Camponovo, F., Deppeler, O., Doerig, R., Heim, H., Humbert-Droz, P., Jung, H., Magaro, L., Sasso, M., Vischer, C., Wanner, J., Wegmann, H. & Ziegler, E. 1971. Die zytostatische Therapie des Prostatakarzinoms. Schweiz Rundschau Med (Praxis) 38, 1276.
   Google Scholar
• Andersson, L., Edsmyr, F., Jönsson, G. & Könyves, I. 1975. Estramustine phosphate therapy in carcinoma of the prostate. In press.
   Google Scholar
• Balogh, F. & Kisbenedek, L. 1974. Treatment of prostatic cancer with Estracyt. Progress in Chemotherapy (ed. G. K. Daikos) vol. III, p. 434.
   Google Scholar
• Forsgren, B., Gustafsson, J.-Å., Pousette, Å. & Högberg, B. 1977. Binding of estramustine, a nitrogen mustard derivative of estradiol in cytosol from rat ventral prostate. In press.
   Google Scholar
• Fosså, S. D. & Miller, A. 1976. Treatment of advanced carcinoma of the prostate with estramustine phosphate. J Urol 115, 406.
   PubMed Web of Science ®Google Scholar
• Høisaeter, P. A. 1975. Incorporation of 3H-thymidine into rat ventral prostate in organ culture. Influence of hormone-cytostatic complexes. Invest Urol 12, 479.
   PubMedGoogle Scholar
• Jacobsen, E. & Nilsson, T. 1975. Remarkable response of oestrogen resistant prostatic carcinoma to Estracyt. Opusc Med 20, 20.
   Google Scholar
• Jönsson, G. & Högberg, B. 1971. Treatment of advanced prostatic carcinoma with Estracyt. Scand J Urol Nephrol 5, 103.
   PubMedGoogle Scholar
• Kirdani, R. Y., Müntzing, J., Varkarakis, M. J., Murphy, G. P. & Sandberg, A. A. 1974. Studies on the antiprostatic action of Estracyt, a nitrogen mustard of estradiol. Cancer Res May 1974, 1031.
   Google Scholar
• Kjaer, T. B., Nilsson, T. & Madsen, P. O. 1975. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of the prostate. Urology 5, 802.
   PubMedGoogle Scholar
• Klein, D. 1972. Behandlung mit Estramustinphosphat bei fortgeschrittenen Prostatakarzinomen. Wiener Med Wochenschr 122, 1.
   PubMedGoogle Scholar
• Leander, G. 1973. Estracyt vid avancerad prostatacancer. Läkartidningen 70, 2237.
   Google Scholar
• de Leval, J., Petit, R. & Bouffioux, C. 1974. Resultats préliminaires de 10 patients porteurs d'une neoplasie prostatique avancée traités par Estracyt. Acta Urolog Belg 42, 326.
   PubMedGoogle Scholar
• Lindberg, B. 1972. Treatment of rapidly progressing prostatic carcinoma with Estracyt. J Urol 108, 303.
   PubMed Web of Science ®Google Scholar
• Mayer, E. J. 1975. Orale Estracyt-Behandlung beim Prostatakarzinom. Ther Umsch 32, 114.
   PubMedGoogle Scholar
• Mittelman, A., Shukla, S. K., Welvaart, K. & Murphy, G. P. 1975. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate. Cancer Chemother Rep 59, 219.
   PubMedGoogle Scholar
• Mittelman, A., Shukla, S. K. & Murphy, G. P. 1976. Extended therapy of stage D carcinoma of the prostate with oral Estracyt. J Urol 115, 409.
   PubMed Web of Science ®Google Scholar
• Müntzing, J., Shukla, S. K., Chu T. M., Mittelman, A. & Murphy, G. P. 1974. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. Invest Urol 12, 65.
   PubMedGoogle Scholar
• Müntzing, J., Varkarakis, M. J., Yamanaka, H., Murphy, G. P. & Sandberg, A. A. 1974. Studies of antiprostatic agents in the baboon. Proc Soc Exp Biol Med 146, 849.
   PubMed Web of Science ®Google Scholar
• Nagel, R. & Kölln, X. P. 1972. Erfahrungen mit Estracyt beim metastasierenden Prostatakarzinom. Aktuelle Urol 3, 241.
   Google Scholar
• Nagel, R. & Kölln, X. P. 1976. Treatment of advanced carcinoma of the prostate with Estracyt. Br J Urol. In press.
   Google Scholar
• Nilsson, T. & Müntzing, J. 1972. Estracyt in advanced prostatic carcinoma. Scand J Urol Nephrol 6, 11.
   PubMed Web of Science ®Google Scholar
• Nilsson, T. & Müntzing, J. 1973. Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt. Scand J Urol Nephrol 7, 18.
   PubMed Web of Science ®Google Scholar
• Nilsson, T. & Jönsson, G. 1975. Clinical results with estramustine phosphate (NSC-89199): A comparison of the intravenous and oral preparations. Cancer Chemother Rep 59, 229.
   PubMedGoogle Scholar
• Nilsson, T. & Jönsson, G. 1975. Primary treatment of prostatic carcinoma with estramustine phosphate (Estracyt): Preliminary report. J Urol 115, 168.
   Web of Science ®Google Scholar
• Plym Forshell, G. & Nilsson, H. 1974. The distribution of radioactivity after administration of labelled estramustine phosphate (Estracyt®), estradiol-17β-phosphate and estradiol-17β to rats. Acta Pharmacol Toxicol, Suppl. I, 35, 28.
   Google Scholar
• Sander, S. 1976. Estracyt-behandling ved cancer prostatae. Tidskr Nor laegeforen 96, 27.
   PubMedGoogle Scholar
• Shukla, S. K., Mittelman, A. & Murphy, G. P. 1974. Oral Estracyt in the treatment of advanced carcinoma of the prostate. Proc Amer Ass Cancer Res 15, 9.
   Google Scholar
• Shukla, S. K., Mittelman, A. & Murphy, G. P. 1975. Long-term treatment of advanced carcinoma of the prostate with oral Estracyt. Proc Amer Ass Cancer Res 16, 229.
   Google Scholar
• Szendröi, Z. & Könyves, I. 1972. Unsere Erfahrungen mit der Estracyt-Behandlung bei Prostatakarzinom. Verh Dsch Ges Urol 24, 301.
   Google Scholar
• Szendröi, Z., Könyves, I., Szendi, L., Eckhardt, S. & Hartay, F. 1974. Estracty in hormone-resistant prostatic carcinoma. Int Urol Nephrol 6, 101.
   PubMedGoogle Scholar
• Welvaart, K., Merrin, C. E., Mittelman, A. & Murphy, G. P. 1974. Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation. Urology 4, 283.
   PubMedGoogle Scholar
• Yagoda, A. 1973. Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma. Cancer 32, 1131.
   PubMed Web of Science ®Google Scholar